Nutra Pharma (NPHC) Ratios
Nutra Pharma Ratios
NPHC's free cash flow for Q2 2026 was $-251.22K. For the 2026 fiscal year, NPHC's free cash flow was increased by $0.00 and operating cash flow was $-251.22K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 0.03 | 0.03 | 0.00 | 0.01 |
| Quick Ratio | 0.03 | 0.02 | 0.02 | 0.00 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Solvency Ratio | -0.11 | 0.62 | -0.60 | -0.06 | -0.97 |
| Operating Cash Flow Ratio | -0.07 | -0.06 | -0.08 | -0.08 | -0.07 |
| Short-Term Operating Cash Flow Coverage | -0.12 | -0.09 | -0.23 | -0.19 | -0.10 |
| Net Current Asset Value | $ -16.95M | $ -12.80M | $ -21.12M | $ -11.74M | $ -11.98M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 16.69 | 11.33 | 10.51 | 16.70 | 24.95 |
| Debt-to-Equity Ratio | -0.58 | -0.69 | -0.39 | -0.44 | -0.72 |
| Debt-to-Capital Ratio | -1.38 | -2.24 | -0.65 | -0.78 | -2.63 |
| Long-Term Debt-to-Capital Ratio | -0.01 | -0.02 | -0.03 | -0.02 | -0.08 |
| Financial Leverage Ratio | -0.03 | -0.06 | -0.04 | -0.03 | -0.03 |
| Debt Service Coverage Ratio | -0.14 | -0.21 | -1.55 | -0.07 | -0.82 |
| Interest Coverage Ratio | -3.32 | -2.41 | -3.87 | -2.75 | -4.46 |
| Debt to Market Cap | 12.55 | 4.06 | 0.56 | 0.62 | 3.51 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -7.16 | -4.54 | -0.65 | -14.17 | -1.39 |
| Profitability Margins | |||||
| Gross Profit Margin | 51.03% | 56.82% | 8.66% | 28.74% | 33.25% |
| EBIT Margin | -379.53% | -435.21% | -12891.84% | -834.36% | -6063.07% |
| EBITDA Margin | -353.20% | -430.03% | -12826.99% | -704.59% | -5988.94% |
| Operating Profit Margin | -379.53% | -435.21% | -1964.61% | -1782.27% | -1118.95% |
| Pretax Profit Margin | -531.37% | 1865.70% | -13399.01% | -1482.14% | -6314.07% |
| Net Profit Margin | -531.37% | 1865.70% | -13399.01% | -1482.14% | -6314.07% |
| Continuous Operations Profit Margin | -531.37% | 1865.70% | -13399.01% | -1482.14% | -6314.07% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 140.01% | -428.69% | 682.02% | 83.16% | 564.29% |
| Return on Assets (ROA) | -350.25% | 1083.15% | -1678.87% | -254.88% | -1939.62% |
| Return on Equity (ROE) | 12.17% | -66.06% | 62.73% | 6.69% | 56.33% |
| Return on Capital Employed (ROCE) | 8.76% | 15.97% | 9.43% | 8.27% | 10.97% |
| Return on Invested Capital (ROIC) | 20.70% | 49.86% | 15.14% | 14.33% | 36.24% |
| Return on Tangible Assets | -350.25% | 1083.15% | -1678.87% | -254.88% | -1939.62% |
| Earnings Yield | -263.20% | 400.00% | -90.53% | -9.70% | -279.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.03 | 20.23 | 0.30 | 1.29 | 3.21 |
| Payables Turnover | 0.22 | 0.26 | 0.13 | 0.06 | 0.12 |
| Inventory Turnover | 9.66 | 7.93 | 2.85 | 7.02 | 8.52 |
| Fixed Asset Turnover | 14.93 | 1.32 | 0.71 | 0.33 | 0.49 |
| Asset Turnover | 0.66 | 0.58 | 0.13 | 0.17 | 0.31 |
| Working Capital Turnover Ratio | 0.00 | -0.03 | -0.01 | -0.00 | -0.01 |
| Cash Conversion Cycle | -1258.29 | -1338.76 | -1405.74 | -5582.40 | -2898.77 |
| Days of Sales Outstanding | 355.17 | 18.04 | 1215.53 | 281.89 | 113.56 |
| Days of Inventory Outstanding | 37.79 | 46.03 | 127.93 | 52.02 | 42.83 |
| Days of Payables Outstanding | 1651.25 | 1402.83 | 2749.20 | 5916.31 | 3055.16 |
| Operating Cycle | 392.97 | 64.07 | 1343.46 | 333.91 | 156.39 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -44.68 | -13.15 | -44.68 | -148.70 | 0.00 |
| Capital Expenditure Coverage Ratio | -44.68 | -13.15 | -44.68 | -148.70 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.12 | -0.09 | -0.21 | -0.17 | -0.09 |
| Operating Cash Flow to Sales Ratio | -3.02 | -1.74 | -17.85 | -16.92 | -7.12 |
| Free Cash Flow Yield | -152.98% | -40.13% | -12.33% | -11.15% | -31.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.33 | 0.25 | -1.10 | -10.31 | -0.36 |
| Price-to-Sales (P/S) Ratio | 2.02 | 4.66 | 148.00 | 152.78 | 22.56 |
| Price-to-Book (P/B) Ratio | -0.05 | -0.17 | -0.69 | -0.69 | -0.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.65 | -2.49 | -8.11 | -8.97 | -3.17 |
| Price-to-Operating Cash Flow Ratio | -0.67 | -2.68 | -8.29 | -9.03 | -3.17 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | -0.00 | 0.11 | -0.02 |
| Enterprise Value Multiple | -7.73 | -5.62 | -1.80 | -35.86 | -1.77 |
| Enterprise Value | 10.52M | 10.60M | 22.57M | 13.11M | 11.05M |
| EV to EBITDA | -7.73 | -5.62 | -1.80 | -35.86 | -1.77 |
| EV to Sales | 27.32 | 24.18 | 230.93 | 252.63 | 105.84 |
| EV to Free Cash Flow | -8.84 | -12.92 | -12.65 | -14.83 | -14.86 |
| EV to Operating Cash Flow | -9.04 | -13.90 | -12.94 | -14.93 | -14.86 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.40 | -4.29 | 1.04 | 1.78 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 4.17 | 4.92 | 19.73 | 21.22 | 11.52 |
| Stock-Based Compensation to Revenue | 0.07 | 0.05 | 1.57 | 0.16 | 0.68 |
| Income Quality | 0.57 | -0.09 | 0.13 | 1.14 | 0.11 |
Currency in USD